Northland Securities analyst Suraj Kalia maintained a Holdrating on Intersect ENT (NASDAQ: XENT) today and set a price target of $32. The company’s shares opened today at $41.10, close to its 52-week high of $42.25.
Kalia wrote:
“We are raising our FY18 and FY19 numbers, in part due to elevated expectations on SINUVA. In our view, this story of marginal beats and “managing Street expectations” is not enough to elevate the stock from its current 10x sales multiple.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.